Genetics of stroke: a review of recent advances

Authors: Domingues-Montanari, Sophie; Mendioroz, Maite; del Rio-Espinola, Alberto; Fernández-Cadenas, Israel; Montaner, Joan

Source: Expert Review of Molecular Diagnostics, Volume 8, Number 4, July 2008 , pp. 495-513(19)

Publisher: Expert Reviews

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Stroke is a multifactorial disease responsible for nearly 10% of deaths each year in industrialized countries. While some monogenic forms of stroke have been described, the vast majority result from the common polygenic form of the disease. Progress in molecular genetics has allowed the identification, through genome-wide linkage analysis, of various candidate genes, including the genes encoding PDE4D and ALOX5AP. Since then, genetic research has been extensively performed from single candidate genes to whole-genome scan studies, in parallel with the development of high-throughput technologies in molecular diagnostics. Additionally, the safety and efficacy of tissue plasminogen activator, the only approved therapy for the acute phase of stroke, is modulated by genetic background associated with the occurrence of hemorrhagic transformations and with the revascularization of the cerebral arteries. In the near future, understanding the contribution of stroke genetic factors will lead to improvements in prevention and treatments for neurovascular diseases.

Keywords: association study; genetics; genome-wide linkage; intracerebral hemorrhage; meta-analysis; stroke; therapy

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737159.8.4.495

Affiliations: 1: Neurovascular Research Laboratory and Neurovascular Unit, Departamento de Medicina - Universitat Autònoma de Barcelona, Institut de Recerca, Hospital Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035 Barcelona, Spain., Email: sophiedomingues@yahoo.fr

Publication date: 2008-07-01

More about this publication?

Expert Review of Molecular Diagnostics provides expert reviews on molecular diagnostic technologies and applied pharmacogenomics in clinical medicine. Coverage includes molecular diagnostics, biomarkers, diagnostic technologies, microarrays and biochips, proteomics, pharmacogenomics, pharmacogenetics and personalized medicine.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites

Genetics of stroke: a review of recent advances

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages